Search Prime Grants

W81XWH2210967

Project Grant

Overview

Grant Description
Exploiting prostate cancer metabolic dependencies to develop new therapeutics and circulating prognostic and predictive biomarkers.
Awardee
The University Of Adelaide
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Australia
Geographic Scope
Foreign
Related Opportunity
W81XWH21PCRPIDA
The University Of Adelaide was awarded Project Grant W81XWH2210967 worth $1,005,845 from Medical Command in September 2022 with work to be completed primarily in Australia. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 9/21/22

Period of Performance
9/30/22
Start Date
9/29/25
End Date
52.0% Complete

Funding Split
$1.0M
Federal Obligation
$0.0
Non-Federal Obligation
$1.0M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2210967

Additional Detail

Award ID FAIN
W81XWH2210967
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
ZNF3SKNJSKM7
Awardee CAGE
Z5G18
Performance District
Not Applicable

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $1,005,845 100%
Modified: 9/21/22